China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review

China NT Pharma Group Co Ltd (1011) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH347663FSA
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

China NT Pharma Group Co Ltd (1011)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

China NT Pharma Group Co Ltd (NT Pharma) is a technology-based pharmaceutical company, which researches, develops, manufactures, and distributes branded and generic pharmaceuticals. The company also promotes and distributes drugs manufactured by third parties. It develops drugs for indications such as cancer; central nervous system disorders; orthopedics; hepatopathy and respiratory disorders. NT Pharma's branded products include Libod and Xi Di Ke for the treatment of various cancers; Miacalcic for bone pain; Shusi, an antipsychotic drug; Zhuo'ao, a respiratory drug, and Songzhi Wan, a traditional Chinese medicine for the treatment of Hepatitis C. The company operates three production bases for chemical drugs, traditional Chinese medicine and bio-chemical drugs through its subsidiaries, Suzhou First, Jiangsu Biopharma and Changsha Pharma. It operates a research and development facility in Beijing. NT Pharma is headquartered in Wanchai, Hong Kong.

China NT Pharma Group Co Ltd Key Recent Developments

Mar 26,2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017

Aug 21,2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017

Jul 31,2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director

Mar 21,2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

China NT Pharma Group Co Ltd-Key Facts 6

China NT Pharma Group Co Ltd-Key Employees 7

China NT Pharma Group Co Ltd-Key Employee Biographies 8

China NT Pharma Group Co Ltd-Major Products and Services 9

China NT Pharma Group Co Ltd-History 10

China NT Pharma Group Co Ltd-Company Statement 12

China NT Pharma Group Co Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Company Overview 14

China NT Pharma Group Co Ltd-Business Description 15

Business Segment: Miacalcic 15

Overview 15

Performance 15

Business Segment: Proprietary Products Production and Sales and Promotion 15

Overview 15

Performance 15

Geographical Segment: Hong Kong 16

Performance 16

Geographical Segment: Other Countries 16

Performance 16

Geographical Segment: PRC 16

Performance 16

R&D Overview 16

China NT Pharma Group Co Ltd-Corporate Strategy 17

China NT Pharma Group Co Ltd-SWOT Analysis 18

SWOT Analysis-Overview 18

China NT Pharma Group Co Ltd-Strengths 18

China NT Pharma Group Co Ltd-Weaknesses 19

China NT Pharma Group Co Ltd-Opportunities 20

China NT Pharma Group Co Ltd-Threats 21

China NT Pharma Group Co Ltd-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

China NT Pharma Group Co Ltd, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Mar 26, 2018: China NT Pharma: Annual Results Announcement For the Year Ended 31 December 2017 33

Aug 21, 2017: China NT Pharma: Interim Results Announcement for the Six Months Ended 30 June 2017 34

Jul 31, 2017: China NT Pharma: Appointment And Resignation Of Non-Executive Director 37

Mar 21, 2017: China NT Pharma Group Company: Annual Results Announcement For The Year Ended 31 December 2016 38

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43

List of Figures

China NT Pharma Group Co Ltd, Performance Chart (2013-2017) 27

China NT Pharma Group Co Ltd, Ratio Charts 29

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

List of Tables

China NT Pharma Group Co Ltd, Key Facts 6

China NT Pharma Group Co Ltd, Key Employees 7

China NT Pharma Group Co Ltd, Key Employee Biographies 8

China NT Pharma Group Co Ltd, Major Products and Services 9

China NT Pharma Group Co Ltd, History 10

China NT Pharma Group Co Ltd, Subsidiaries 13

China NT Pharma Group Co Ltd, Key Competitors 22

China NT Pharma Group Co Ltd, Ratios based on current share price 23

China NT Pharma Group Co Ltd, Annual Ratios 24

China NT Pharma Group Co Ltd, Annual Ratios (Cont...1) 25

China NT Pharma Group Co Ltd, Annual Ratios (Cont...2) 26

China NT Pharma Group Co Ltd, Interim Ratios 28

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

China NT Pharma Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

China NT Pharma Group Co Ltd, Recent Deals Summary 32

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Zhejiang Hisun Pharmaceutical Co Ltd

Xian-Janssen Pharmaceutical Ltd

Sumitomo Pharmaceuticals (Suzhou) Co Ltd

Beijing Tiantan Biological Products Co Ltd

Beijing SL Pharmaceutical Co Ltd

Beijing Beilu Pharmaceutical Co Ltd

Anhui Anke Biotechnology (Group) Co Ltd

China NT Pharma Group Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8873
Site License
USD 250 INR 17745
Corporate User License
USD 375 INR 26618

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com